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ABSTRACT Treatment of mouse lymphoma $49 cells with D,L-~x-difluoromethylornithine 
(DFMO), an inhibitor of ornithine decarboxylase, depleted cellular polyamine levels and 
stopped cell growth. The cells were arrested predominantly in G1. Thus, polyamine depletion 
may lead to a regulatory growth arrest in $49 cells. We tested two hypotheses regarding the 
relationship of growth arrest mediated by polyamine limitation to that mediated by cyclic AMP 
(cAMP). The hypothesis that cAMP-induced arrest results from polyamine depletion is not 
tenable, because the arrest could not be reversed by addition of exogenous polyamines, and 
because cellular polyamine levels do not drop in dibuturyl cyclic AMP (Bt2cAMP)-arrested 
cells. The hypothesis that polyamine-mediated growth arrest is effected via modulation of 
cAMP levels or cAMP-dependent protein kinase activity was also shown to be incorrect, 
because a $49 variant deficient in cAMP-dependent protein kinase was arrested by DFMO. The 
activities of the polyamine-synthesizing enzymes ornithine decarboxylase (ODC) and S-aden- 
osyl methionine decarboxylase (SAMD) are both reduced in Bt2cAMP-treated cells to about 
10% of that in control populations, as shown previously. DFMO diminishes ODC activity and 
augments SAMD activity in both untreated and Bt2cAMP-treated cells, leading to polyamine 
depletion in both cases. 
Numerous studies indicate that the polyamines putrescine, 
spermidine, and spermine influence cell proliferation. Two 
sorts of evidence support his: first, polyamine levels and the 
activities of their synthesizing enzymes, ornithine decarboxyl- 
ase (ODC) and S-adenosyl methionine decarboxylase 
(SAMD), vary with the proliferative state of the cell (1), and 
second, pharmacologically induced depletion of cellular poly- 
amines leads to reduced cellular proliferation (2-11). Polya- 
mines may simply be necessary constituents for proliferating 
cells or they may be regulatory molecules, ignaling the cells to 
initiate or cease proliferation. 
We ask here whether polyamines are necessary for growth 
of mouse lymphoma $49 cells, whether they behave as regu- 
latory molecules with respect o cell cycle specificity of arrest, 
and finally whether causal connections exist among regulatory 
systems controling cyclic AMP (cAMP), polyamines, and cell 
growth. 
ODC is the enzyme responsible for synthesis of putrescine 
from ornithine. Spermidine and spermine are generated from 
putrescine by addition of one and two aminopropyl groups, 
respectively. SAMD generates the aminopropyl donor mole- 
cules for this reaction and is the rate-limiting enzyme for the 
synthesis of these higher polyamines. We show here that treat- 
ment of $49 cells with a-difluoromethylornithine (DFMO), an 
enzyme-activated irreversible inhibitor of ODC, depletes cells 
of polyamines and halts cell proliferation. Because regulators 
of cell growth act primarily to change the duration of the G1 
phase of the cell cycle (12) we assume that a G1 arrest is 
suggestive of a regulatory growth arrest. S49 cells show a 
predominantly GI phase arrest with DFMO treatment. This 
indicates that in these cells polyamines are potentially regula- 
tory molecules. Previous work has demonstrated that treatment 
of $49 cells with biologically active cAMP analogues uch as 
dibutyryl cAMP (Bt2cAMP) arrests cells in the GE phase (13) 
and extinguishes the activities of ODC and of SAMD (14, 15). 
Both responses are mediated via the cAMP-dependent protein 
kinase, as both are abolished in $49 mutant cells devoid of that 
kinase (13-15). 
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On the basis of these data, a causal model can be drawn; 
cAMP levels rise, cAMP kinase is activated, ODC and SAMD 
are inactivated, polyamine levels decrease, and Gt arrest results 
from the depletion of polyamines. We show here that this 
model is wrong. A second model that connects polyamines and 
cAMP may be considered: DFMO reduces ODC activity, 
polyamine levels decrease, this leads to increased cAMP levels, 
cAMP kinase is activated, and G1 arrest ensues. We show that 
this model also is incorrect and conclude therefore that cAMP 
and polyamines influence cell growth through mechanisms 
whose initial steps, at least, are distinct. 
MATERIALS AND METHODS 
Data in all figures and tables are from representative experiments, each of which 
was repeated multiple times. 
Cell Culture: In these studies we have used mutant $49 ceils (deathless 
variant, clone 21 I. 1.2), which have all the growth regulatory responses to elevated 
cAMP levels of wild type ceils but which, unlike wild type $49 cens, do not die 
in response to elevated cAMP (14, 16). This is necessary to distinguish cAMP's 
effects on polyamines due to growth arrest from those due to cellular death. Ceils 
were maintained in Dulbecco's modified Eagle's (DME) medium, 3gm/l  glucose, 
and 10 percent heat-inactivated horse serum at cell densities from 10 ~ to 106 per 
ml. Cell numbers were determined with an electronic particle counter (Coulter 
model ZBI, Coulter Electronics Inc~, Hialeah, FL). 
Enzyme Assays: ODC and SAMD assays were performed as described 
(14) except that the released ~4COe was trapped on a piece of filter paper 
(Whatman 3 mm, Whatman Inc.. Paper Div., Clifton, NJ) spotted with 10 ,td l 
M hyamine hydroxide. In both assays enzyme activities were linear with time 
and proportional to the amount of protein added. Cellular lysates for enzyme 
assays were prepared from cells washed once with cold phosphate-buffered saline 
(PBS) and resuspended in hypotonic buffer (5 mM Tris HCI pH 7.5, 2 mM 
dithiothreitol) at a concentration f 4 x l07 cells/ml. Cells were quick-frozen in 
a dry ice-ethanol bath and stored in liquid nitrogen. Cells were lysed by a total 
of three cycles of freeze-thawing. Homogenates were centrifuged at 100,000 g for 
60 min and the supernatants a sayed. In some cases the superuatants were again 
stored in liquid nitrogen until assayed. 
Polyamine Measurements: Cells were washed one time with PBS 
and centrifuged. The PBS was decanted and the tubes were wiped to remove all 
excess olution. Cell pellets were resuspended in 8% fresh 5-sulfosalicycllc acid 
(250 #l/pellet or 3.5 x l07 cells/250 #l, both methods gave the same results). 
Polyamine levels were measured as described (9). 
Flow Cytometry: The distribution of cell populations in the cell cycle 
was determined by staining ethanol-fixed cells with chromomycin and analyzing 
them with a flow cytometer (FCM) at the Lawrence Livermore Laboratory as 
described (17). 
Experimental Design: Cells were fed by a threefold ilution, allowed 
to grow 1 d, and again fed, this time by fivefold dilution with medium containing 
the appropriate drug. Polyamine levels, cell numbers, and FCM distribution were 
measured at indicated times fol/owmg drug addition. 
RESULTS 
Effects of Polyamine Depletion on Cell Growth 
Treatment of $49 cells with DFMO stopped cell growth (Fig. 
1). This effect was completely prevented by adding 10 #M 
putrescine along with the drug. Putrescine's ability to abolish 
DFMO's growth inhibitory effect indicates that the inhibition 
is due to polyamine depletion and not to some nonspecific 
effect of the drug. Cells arrested by 3 d of drug treatment could 
be'made to resume growth by refeeding with fresh medium 
containing putrescine. DFMO treatment of $49 cells was not 
very toxic; it reduced their cloning efficiency in medium con- 
taining putrescine to 76% in 2 d and 70% in 3 d, relative to 
control cells. Refeeding with fresh medium alone did not 
reverse the growth arrest. This result further supports the 
specificity of DFMO by ruling out the possibility that putres- 
cine abolishes the effect of DFMO by reducing its uptake into 
cells. 
The kinetics of DFMO arrest were the same regardless of 
whether cultures were treated at initial cell densities as low as 
104 per ml or as high as 106 per ml (data not shown). Initial cell 
densities lower than 104 per ml could not be tested, as $49 cells 
do not grow exponentially under these conditions. Therefore, 
we have no evidence for or against the hypothesis that arrest 
is mediated by a factor released by DFMO-treated $49 cells, as 
has been demonstrated for CHO cells (18). 
Measurement of intracellular levels of polyamines (Table I) 
showed that DFMO treatment led to a depletion of spermidine. 
Putrescine addition replenished spermidine pools. Putrescine 
levels in $49 cells were too low to be reliably measured with 
the number of cells used, except when cells were treated with 
exogenous putrescine. In those experiments in which the 
amount of endogenous putrescine could be measured, its mod- 
ulation paralleled that of spermidine. These data imply that 
depletion of spermidine and perhaps putrescine leads to ces- 
sation of cell proliferation. 
Cell Cycle Specificity of DFMO Arrest 
To determine the cell cycle specificity of DFMO arrest, we 
analyzed control and DFMO-treated cells by flow cytometry 
(FCM), a procedure that measures DNA content per cell and 
thus determines the distribution of the cell population among 
the Gx, S, and G2 + M phases of the growth cycle. FCM 
measurements are shown of cells treated with DFMO for 24, 
48, and 72 h, and of untreated and DFMO plus putrescine- 
treated cells at 24 h (Fig. 2). FCMs of untreated control ceils 
and DFMO plus putrescine-treated cells at 48 and 72 h are not 
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FIGUR[ I Effect of DFMO on cell growth and its reversal by pu- 
trescine. $49 cells were grown without  drugs (O) or in the presence 
of 0.1 mM DFMO (&), DFMO plus putrescine (O), or DFMO 
fol lowed by 74 h with medium alone (1:3) or with medium containing 
putrescine ( I ) ,  as described in Materials and Methods. After re- 
moval from medium containing DFMO, $49 cells were resuspended 
at 3 x 10 s cells/ml and treated with 0.1 mM DFMO or with 10/tM 
putrescine as indicated. Data are summarized from two experiments. 
For reversal of DFMO treatment, $49 cells were counted with a 
hemocytometer. 
TABLE I 
Measurement of Intracellular Levels of Polyamines 
Treatment Spermidine Spermine 
nm/10 e cells 
None 0.69 0.84 
DFMO 0.017 0.30 
DFMO + Putrescine 1.20 0.59 
Effect of DFMO and putrescine on cellular polyamine pools. $49 cells were 
treated as in Fig. 1 and harvested for polyamine measurements after 49 h of 
drug treatment. 
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FIGURE 2 Cell cycle distribution of DFMO treated cells. Cells were treated as in Fig. 1 and FCM measurements taken at 24, 48, and 
72 h. FCM measurements of DFMO-treated cells are shown at all time points. FCM measurements of untreated and DFMO plus 
putrescine-treated cells are shown at 24 h only, as discussed in the text. Data are displayed as fluorescence per cell on the abscissa 
and as cell number on the ordinate, both in arbitrary units. 
included as exponentially growing cultures have reached very 
high cell densities by 48 h. When cells were plated at lower 
densities, they did not show FCM pertubations after 48 and 72 
h but did when similarly high cell densities were reached (data 
not shown). In these experiments, DFMO- and Bt2cAMP- 
arrested cells at no time reached cell densities at which un- 
treated cells show FCM pertubations. The fraction of cells in 
the G1 phase was slightly increased after 1 d of treatment with 
DFMO; after 3 d the effect was pronounced. This implies that 
the growth inhibition produced by DFMO results from a 
prolongation of G1 relative to other phases of the cell cycle. 
Such a Gl-specific growth arrest is consistent with a potentially 
regulatory role for polyamines. DFMO's effect on cell cycle 
distribution was completely prevented by the addition of 10 
/~M exogenous putrescine. Treatment of cells with DFMO in 
medium containing dialyzed horse serum rather than unmod- 
ified horse serum changed neither the kinetics nor the cell cycle 
specificity of arrest (data not shown). Therefore, the amount of 
polyamines in the horse serum is insufficient o affect the 
response. 
Interrelation between cAMP and Polyamine 
Growth Regulatory Systems in $49 Cells 
We tested in a number of ways the hypothesis that Bt2cAMP- 
mediated arrest of $49 ceils occurs via depletion of intracellular 
polyamines. This hypothesis predicts that the arrest should be 
reversed by replenishing polyamine pools. There was no effect 
on the kinetics of Bt2cAMP arrest when exogenous putrescine 
was added at a concentration that completely prevents growth 
inhibition by DFMO (Fig. 3). Nor did the addition of putres- 
cine have any effect on the FCM distribution of Bt2cAMP 
arrested cells (Fig. 4). In order to show that the exogenous 
putrescine ntered the cells and effectively replenished pools, 
we measured intracellular polyamines. Fig. 5 shows that ex- 
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FIGUR[ 3 EffeCt of putrescine and Bt2cAMP on growth of $49 cells. 
$49 cells were untreated (O) or treated with either 0.5 mM Bt~cAMP 
(ll) or Bt2cAMP plus 10 #M putrescine ([]]) and cell number was 
measured. 
ogenous putrescine ntered Bt2cAMP-treated ceils and was 
metabolized to spermidine; spermidine pools were elevated 
above control evels in cells treated with both putrescine and 
Bt2cAMP. Putrescine pools were also elevated to easily mea- 
surable levels, i.e., above control levels (data not shown). 
Therefore, Bt2cAMP arrest is not reversed by elevation of 
polyamine pools. This implies that the arrest is not mediated 
via depletion of polyamine pools. 
Intracellular polyamine pools were measured as a function 
of time in untreated cultures and in cultures treated with 
DFMO, DFMO plus putrescine, Bt2cAMP, Bt2cAMP plus 
putrescine, and Bt2cAMP followed 24 h later with DFMO (Fig. 
5). All cultures were refed with fresh medium at the time of 
drug addition. As previously discussed, putrescine l vels were 
too low to measure reliably but appeared to vary directly with 
spermidine levels (data not shown). Spermine pools stayed 
relatively constant under all conditions (data not shown), as 
reported for other cell types (5-10, 18, 19). Spermidine pools 
rose about twofold in untreated control cells during the 50-h 
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FIGURE 4 Effect of putrescine on the celt cycle distr ibution of  
Bt2cAMP-arrested $49 cells. $49 cells were treated as in Fig. 3 and 
FCM measurements taken at 26 h. Data are displayed as in Fig. 2. 
course of the experiment, rose even more rapidly in putrescine- 
treated cells, fell precipitously in DFMO-treated cells, and 
remained constant in Bt2cAMP-treated cells. Since polyamine 
levels do not drop in Bt2cAMP-treated cells we can again 
conclude that the arrest is not mediated through modulation of 
polyamine levels. This result was unexpected as ODC and 
SAMD activities drop to about 10% of control values under 
these conditions. Clearly, that reduced activity is sufficient o 
maintain polyamine pools during growth arrest. Further treat- 
ment of Bt2cAMP-treated ceils with DFMO at 24 h led to a 
decrease in spermidine levels, indicating that the remaining 
ODC activity can be pharmacologically inhibited and is indeed 
required to maintain polyamine pools. Similar experiments 
that included longer time courses howed that DFMO contin- 
ues to deplete spermidine levels in Bt2cAMP-treated cells to 
10% of values in cultures treated with Bt2cAMP alone (data 
not shown). 
Fig. 6 shows the activities of ODC and SAMD under the 
same conditions as used in the experiments shown in Fig. 5. 
Cultures refed with medium alone exhibited increases in both 
ODC and SAMD activities. This stimulation accounts for the 
increase in spermidine pools seen in Fig. 5. DFMO treatment 
of cells rapidly extinguished ODC activity and produced a 
slight augmentation of SAMD activity. This enhancement of
SAMD activity was more prominent in other experiments. 
DFMO induction of SAMD has been reported in other cell 
systems, and it was suggested that SAMD induction was stim- 
ulated by reduced polyamine levels (7, 11, 20-23). Bt2cAMP 
treatment of ceils led to a small early rise followed by a 
precipitous drop in both ODC and SAMD activities, as previ- 
ously reported (14); each fell to -10% of its initial value by 10 
h. Subsequent treatment of Bt2cAMP-treated cells with DFMO 
dropped ODC activity further and induced SAMD activity. 
The induction of SAMD was abolished by the addition of 
putrescine along with DFMO, suggesting that the reduction of 
polyamine pools is the signal for the induction. 
Studies in this and in other laboratories have shown that the 
kin- $49 cell mutant is devoid of measurable cAMP-dependent 
protein kinase activity and lacks all responses to elevated 
cAMP levels (14, 24, 25). We tested the hypothesis that DFMO 
arrest is modulated through the cAMP kinase by using this 
mutant. Deathless (kin + ) and kin- cells were treated in parallel 
with DFMO, and cell growth and FCM measurements were 
made. Both cell types were arrested, and the kinetics of the 
arrest were identical (data not shown). FCM measurements 
made 72 h after treatment with DFMO were identical in the 
two cell types, indicating that the change in cell cycle distri- 
bution of the arrested cells is also not mediated via the cAMP 
kinase (Fig. 7). Therefore the arrest and change in cell cycle 
distribution induced by DFMO cannot be modulated via 
cAMP kinase, as the arrest and redistribution occur identically 
in cells having or lacking that kinase. 
DISCUSSION 
The major conclusions we draw from these data are that 
polyamine depletion arrests the growth of $49 cells, that the 
cell cycle specificity of the arrest is characteristic of a regulatory 
response, and that this arrest is dissociable from cAMP-medi- 
ated arrest. 
We have shown that DFMO-mediated arrest is due to poly- 
amine depletion. It is possible that the arrest is due to a 
secondary effect of polyamine depletion rather than being a 
direct response to lowered polyamine levels. For example, the 
increased SAMD activity accompanying polyamine depletion 
could lead to decreased levels of S-adenosylmethionine a d/or 
increased levels of decarboxylated S-adenosylmethionine. This 
possibility has been discussed in other reports (26, 27). 
$49 cells arrested by DFMO are predominantly in G1. We 
recognize that this suggests a Gl-specific block but does not 
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FIGURE 5 Spermidine levels in $49 cells treated with various com- 
binations of  DFMO, putrescine, and Bt2cAMP. Cells were treated as 
described in Materials and Methods and harvested for polyamine 
measurements. Drug concentrations are the same as those in pre- 
vious figures. Control  (O), DFMO (&), Bt2cAMP ( l l  L DFMO plus 
putrescine (A), Bt2cAMP plus putrescine (FI), and Bt2cAMP fo l lowed 
at 24 h with DEMO (~11.). 
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FIGURE 6 Time course of ODC and SAMD activities in $49 cells treated with various combinations of DFMO, putrescine, and 
Bt2cAMP. S49 cells were treated with drugs, lysates prepared, and assayed for ODC and SAMD. Control (@), DFMO (&), Bt2cAMP 
(111), Bt2cAMP followed at 24 h with DFMO (El), and Bt2cAMP followed at 24 h with DFMO and putrescine (41,). Drug concentrations 
are the same as in previous figures. 
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prove that progression through other phases of the cell cycle is 
unaffected. Further studies are needed to resolve this. The 
growth inhibition induced by polyamine depletion in $49 cells 
is neither so prompt nor so complete as that induced by 
activation of cAMP-dependent protein kinase. Whether and, 
if so, under what conditions intracellular depletion of polya- 
mines is of physiologic significance in regulating cell growth 
remains to be established. 
In all cases the activities of polyamine synthetic enzymes are 
consistent with the modulations in polyamine pools. Bt2cAMP 
treatment leads to a coordinate lowering of ODC and SAMD 
activities; the polyamine pools are little perturbed. DFMO 
lowers ODC and induces SAMD; putrescine l vels are reduced, 
and the remaining spermidine isconverted to spermine and/or 
other products. This occurs either when cells are treated with 
DFMO alone or when DFMO treatment follows Bt2cAMP 
treatment. Thus the ODC activity that remains in Bt2cAMP- 
treated ceils is functional in maintaining polyamine levels. The 
kinetics of modulation of ODC activity and cell division by 
DFMO and Bt2cAMP do not differ greatly, yet DFMO drast- 
ically reduces permidine l vels, ,whereas permidine l vels are 
little perturbed in Bt2cAMP-treated cultures. Therefore, 
Bt2cAMP-treated ceils must maintain their spermidine pools 
largely by reducing SAMD activity, thus reducing the rate of 
conversion of spermidine to spermine, or possibly by reducing 
the rate of spermidine's metabolic onversion through other 
pathways, such as oxidation or acetylation. It appears that 
ODC and SAMD activities are modulated in a way that retains 
normal polyamine levels during BtzcAMP arrest. 
Russell et al. (28) reported polyamine levels, ODC activities, 
and SAMD activities in $49 cells treated with Bt2cAMP. Their 
data differ from ours in that they found that polyamine levels 
had dropped in cells treated with Bt2cAMP for 24 h. This 
difference may be attributable to the fact that they used wild 
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untreated )FMO 
DNA content 
FIGURE 7 Effect of DFMO on the ceil cycle distribution of kin* and 
kin- $49 cells. Kin- and deathless (kin +) $49 cells were grown with 
and without 0.1 mM DFMO for 72 h and analyzed by FCM. 
type $49 cells, whereas we used the cAMP deathless variant. 
This variant, although identical to the wild type in its growth 
response to DFMO (unpublished) and Bt~cAMP (16), is resist- 
ant to the cytolytic effect of Bt2cAMP. Interpretation of their 
results is also made difficult by the fact that their control 
cultures were neither growing exponentially nor maintaining 
stable ODC activities during the course of the experiments 
reported. Our results, however, support and extend their con- 
clusion that, in viable cells, cAMP has little effect on spermi- 
dine pools. 
We have tested two models that connect cAMP- and poly- 
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amine-mediated arrests of  $49 cells: first, that cAMP arrest is 
mediated by lowering polyamine pools, and second, that poly- 
amine arrest is mediated via cAMP-dependent kinase. Both 
models are incorrect. Therefore, the initial steps for arrest 
mediated by cAMP and polyamines are distinct. 
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